Observational study · people
Melanotan II: oral melanoma case in a 22-year-old nasal spray user
Checked against the paper Observational studyPublished by PepVault
The takeaway
This report adds one documented case of mouth melanoma in a young Melanotan II nasal spray user, a possible link the authors say people should be aware of.
- Kind
- Observational study
- Studied in
- People
- Published
- 2025
- Journal
- Int J Oral Maxillofac Surg
What they tested
The authors described one patient who developed a cancer in the mouth after using Melanotan II, and looked at past reports on whether Melanotan use is linked to melanoma.
How the study was done
A single case report of a 22-year-old woman who had used Melanotan II nasal spray to tan, paired with a review of earlier published reports on Melanotan and melanoma.

What they found
The woman developed a lump at the front of her upper jaw. Tissue tests under the microscope showed it was a mucosal malignant melanoma, a skin-type cancer growing in the lining of the mouth. She had surgery to remove it and then continued immunotherapy, a treatment that uses the immune system against cancer. The authors flag this as a possible serious side effect of Melanotan II nasal spray.
What it doesn’t show
This is one person, so it can't show that Melanotan II caused the cancer or how often this might happen. There was no comparison group.
The paper
Yassin Alsabbagh et al. Melanotan II nasal spray: a possible risk factor for oral mucosal malignant melanoma?. Int J Oral Maxillofac Surg. 2025.
The compounds
More studies on Melanotan II
- Melanotan II: erections in 17 of 20 men with erectile dysfunctionClinical trial · people · 2000
- Melanotan II: erections in 8 of 10 men with psychogenic EDClinical trial · people · 1998
- Melanotan II: darker skin in 2 of 3 men in a small phase I trialClinical trial · people · 1996
- Melanotan II: melanoma diagnosed in a 20-year-old woman after useObservational study · people · 2014
- Every study on Melanotan II
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.